Acepodia and JW Therapeutics Enter into Option and License Agreement for Off-the-shelf NK Cell Therapies

JW therapeutics to receive exclusive licenses to develop and commercialize ACE1702 and ACE1655 in Mainland China, Hong Kong, and Macau Acepodia to receive upfront and milestone payments in addition to …
( read original story …)

---